Literature DB >> 15988744

HPLC separation of hesperidin and the C-2 epimer in commercial hesperidin samples and herbal medicines.

Nahoko Uchiyama1, Ik Hwi Kim, Nobuo Kawahara, Yukihiro Goda.   

Abstract

Hesperidin (2S-form), the flavanone 7-O-glycoside, is the main constituent of some Citrus species. The peels of two Citrus species are used as a crude drug, Aurantii nobilis pericarpium, in the Japanese Pharmacopoeia and as components in Kampo formulae. Thus, HPLC analysis of hesperidin as a marker compound is needed for quality control of medicines. Hesperidin was separated from the corresponding C-2 epimer by normal-phase HPLC using a chiral column. Moreover, narirutin and neohesperidin were also separated from the corresponding C-2 epimer. The analyses of commercial hesperidin samples revealed that they contained the C-2 epimer and that the relative ratio of hesperidin to the epimer ranged from 92:8 to 59:41. The HPLC application to Citrus extracts suggested that naturally occurring hesperidin in Citrus has the 2S configuration; however, the dry extracts of rikkunshito and chotosan, which are Kampo formulations containing Aurantii nobilis pericarpium, were found to contain a considerable amount of the (2R)-epimer. These data suggest that the decoction process of the formulae partly converts hesperidin to the epimer. Because diastereomers differ from each other in physicochemical and biological activities, HPLC to separate hesperidin from the C-2 epimer should be introduced into the letter of approval for herbal medicines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988744     DOI: 10.1002/chir.20175

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  2 in total

1.  Usage and attitudes of physicians in Japan concerning traditional Japanese medicine (kampo medicine): a descriptive evaluation of a representative questionnaire-based survey.

Authors:  E C Moschik; C Mercado; T Yoshino; K Matsuura; K Watanabe
Journal:  Evid Based Complement Alternat Med       Date:  2012-01-26       Impact factor: 2.629

Review 2.  Regulatory science of natural products.

Authors:  Yukihiro Goda
Journal:  J Nat Med       Date:  2022-07-23       Impact factor: 3.192

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.